Company news

Share this article:
Abbott Laboratories has announced plans to acquire Ibis Biosciences, the molecular diagnostics division of Isis Pharmaceuticals. Abbott invested $40 million in the company earlier this year, and will purchase all remaining equity for $175 million. 
 
Wyeth Pharmaceuticals has announced the acquisition of Thiakis Limitied, a privately held biotech based in the UK. Thiakis lead product candidate, TKS 1225, will potentially treat obesity and other co-morbidities. 
 
New England-based pharma research firm Charles River Laboratories will invest $20 million and create 60 jobs by expanding its Charleston, SC, operations.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.